Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Recovery After ICU Treatment: A Prospective Cohort Study

29 maggio 2018 aggiornato da: Stine Estrup, Zealand University Hospital

This project aims to investigate the physical, mental and cognitive recovery after admission to the Intensive Care Unit (ICU).

This will be done by a three and 12 month follow up after discharge. The patients will be scored with four validated methods for evaluating their health related quality of life, anxiety and depression, cognitive function and physical impairments

Panoramica dello studio

Stato

Completato

Descrizione dettagliata

An increasing number of patients are treated at ICUs worldwide. The majority of these patients survive critical illness and are discharged from the hospital. A stay at the ICU is most often related to life-threatening conditions and displays a major impact on both physical and mental resources of the patients. Studies have shown that a great part of these patients also have physical and psychological impairments lasting for a long period after their hospital stay. The condition is termed the "post intensive care syndrome" (PICS) and describes a state with wide range of symptoms as fatigue, depression, anxiety, memory loss as well as both cognitive and physical impairment. During the first five years after discharge, more than half of ICU survivors had suffered at least one episode of depression or anxiety

ICU treatment often involves immobilization and sedation that may lead to both muscle weakness, critical illness myopathy and/or polyneuropathy. This may not only affect the patients during the ICU or hospital stay, but also for a longer post-discharge period. A recent study demonstrated that measured physical health related quality of life was impaired for up to one year after hospitalization, and that the physical performance at five years post-discharge continued to be lower than in the background population. The physical impairments may also influence patient's working ability, and among previously working individuals only half had returned to work within the first year after ICU hospitalization. After five years, up to 25 % still had not returned to work.

In Denmark, more than 30.000 people are annually admitted to intensive care units. The annual report from the Danish Intensive Care Database (DID) present data regarding a variety of outcomes, including length of stay, survival rate and 90 days re-admission to hospital. The reports demonstrate an increased quality of care but offer limited information on longer term outcome including quality of life for these patients. A recent study have indicated that Danish patients might suffer from the same psychological and physical impairments as found in international studies, but a better characteristic of the population is needed. Especially since the level of public care, including early rehabilitation in hospital differs between countries.

It is therefore essential to investigate and describe the needs, standard of care and the physical and cognitive status of these patients both in-hospital and post-discharge in order to establish the right level of aftercare for the Danish population. This study aims at investigating the in-hospital care as well as the physical and cognitive status of a Danish cohort of ICU patients at 3 and 12 month post-discharge.

The investigators plan to do a substudy regarding exposure to circadian light and delirium.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

161

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Køge, Danimarca, 4600
        • University Hospital Zealand, Køge

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Patients admitted to the ICU at Zealand University Hospital, Køge, in the study period

Descrizione

Inclusion Criteria:

  • Patients > 18 years of age
  • Admitted to the ICU for > 24 h

Exclusion Criteria:

  • Not able to speak and understand Danish
  • Discharged from the ICU to terminal care
  • Patients transferred to another hospital during ICU stay
  • Patients living outside the Region of Zealand
  • Patient with severe dementia

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cognitive function measured by Repeatable Battery for the Assessments of Neuropsychological Status (RBANS)
Lasso di tempo: 3 months after discharge
The Repeatable Battery for the Assessments of Neuropsychological Status (RBANS) evaluation status at 3 and 12 months after discharge from ICU
3 months after discharge

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Adherence to checklist based on rehabilitation guidelines
Lasso di tempo: At discharge from hospital and 3 months
Adherence to a checklist at discharge from ICU and hospital that evaluates rehabilitation efforts based on guidelines from NICE (the National Institute for Health and Care Excellence)
At discharge from hospital and 3 months
Health related quality of life measured by Short form health survey (SF 36)
Lasso di tempo: 3 and 12 months
Short form health survey (SF 36) score at 3 and 12 month follow up
3 and 12 months
Anxiety and depression measured by Hospital anxiety and depression scale (HADS)
Lasso di tempo: 3 and 12 months
Hospital anxiety and depression scale (HADS) score at 3 and 12 month follow up
3 and 12 months
Physical function measured by Chelsea critical care physical assessment tool (CPAx)
Lasso di tempo: 3 and 12 months
Chelsea critical care physical assessment tool (CPAx) at 3 and 12 month follow up
3 and 12 months
Mortality
Lasso di tempo: At discharge from hospital (variable time) and at 90 days postdischarge
All cause mortality
At discharge from hospital (variable time) and at 90 days postdischarge
Delirium at the ICU measured by CAM-ICU
Lasso di tempo: At discharge from ICU (variable time)
Delirium during ICU stay, measured as days with a positive CAM-ICU score or CAM-ICU negative delirium treated with anti-psychotics
At discharge from ICU (variable time)
Consumption of opioids at admission and on follow up
Lasso di tempo: At admission to hospital, at 3 month follow up
Percentage of patients with a daily consumption of opioids (strong/weak) at hospital admission and at 90 days discharge
At admission to hospital, at 3 month follow up
Consumption of anti-depressants before and after ICU stay
Lasso di tempo: At admission to hospital, at 3 month follow up
Percentage of patients with a daily consumption of anti-depressants at hospital admission and at 90 days after discharge
At admission to hospital, at 3 month follow up
Receiving statins before and after ICU stay
Lasso di tempo: At admission to hospital, at 3 month follow up
Percentage of patients with a daily consumption of statins at hospital admission and at 90 days after discharge
At admission to hospital, at 3 month follow up
Cognitive function measured by Repeatable Battery for the Assessments of Neuropsychological Status (RBANS)
Lasso di tempo: 12 months after discharge
The Repeatable Battery for the Assessments of Neuropsychological Status (RBANS) evaluation status at 3 and 12 months after discharge from ICU
12 months after discharge

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Cattedra di studio: Ole Mathiesen, MD, Zealand University Hospital, Køge Hospital

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 febbraio 2016

Completamento primario (Effettivo)

1 marzo 2018

Completamento dello studio (Effettivo)

1 maggio 2018

Date di iscrizione allo studio

Primo inviato

4 novembre 2015

Primo inviato che soddisfa i criteri di controllo qualità

5 novembre 2015

Primo Inserito (Stima)

6 novembre 2015

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

30 maggio 2018

Ultimo aggiornamento inviato che soddisfa i criteri QC

29 maggio 2018

Ultimo verificato

1 maggio 2018

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • SE 1-16

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Qualità della vita

Sottoscrivi